Christopher Bryce Johnson
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- CAR-T cell therapy research
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 3
-
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Moira Katherine Rushton (3 shared papers)David J. Cole (6 shared papers)Mark P. Rubinstein (6 shared papers)Shikhar Mehrotra (6 shared papers)Reshma Jagsi (1 shared paper)Susan Faye Dent (2 shared papers)Chrystal Mary Paulos (5 shared papers)Zihai Li (3 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Oncotarget (2 papers)OncoImmunology (2 papers)Science Translational Medicine (1 paper)Echo Research and Practice (1 paper)
- Partner nations
- United StatesCanadaEgypt
In The Last Decade
Christopher Bryce Johnson
30 papers receiving 818 citations
Peers
Comparison fields: 5 of 90
- Oncology 273
- Cardiology and Cardiovascular Medicine 205
- Immunology 143
- Pulmonary and Respiratory Medicine 139
- Cancer Research 47
Countries citing papers authored by Christopher Bryce Johnson
This map shows the geographic impact of Christopher Bryce Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bryce Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bryce Johnson more than expected).
Fields of papers citing papers by Christopher Bryce Johnson
This network shows the impact of papers produced by Christopher Bryce Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bryce Johnson. The network helps show where Christopher Bryce Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Bryce Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2001 | 86 | |
| 3 | 2020 | 84 | |
| 4 | 2010 | 67 | |
| 5 | 2015 | 51 | |
| 6 | 2016 | 45 | |
| 7 | 2016 | 36 | |
| 8 | 2017 | 36 | |
| 9 | 2015 | 35 | |
| 10 | 2016 | 34 | |
| 11 | 2016 | 33 | |
| 12 | 2017 | 29 | |
| 13 | 2019 | 28 | |
| 14 | 2019 | 25 | |
| 15 | 2015 | 22 | |
| 16 | 2018 | 22 | |
| 17 | 2013 | 21 | |
| 18 | Impending paradoxical embolus: a case report and review of the literature. | 2003 | 19 |
| 19 | 2020 | 15 | |
| 20 | 2022 | 14 |
About Christopher Bryce Johnson
Christopher Bryce Johnson is a scholar working on Oncology, Immunology, Cardiology and Cardiovascular Medicine, Hepatology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 844 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (273 citations), Cardiology and Cardiovascular Medicine (205 citations), Immunology (143 citations), Pulmonary and Respiratory Medicine (139 citations) and Cancer Research (47 citations). Christopher Bryce Johnson has collaborated with scholars based in United States, Canada and Egypt. Frequent co-authors include Moira Katherine Rushton, David J. Cole, Mark P. Rubinstein, Shikhar Mehrotra, Reshma Jagsi, Susan Faye Dent, Chrystal Mary Paulos, Zihai Li, Jeffrey M. Macdonald and Haakil Lee. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Oncotarget, OncoImmunology, Science Translational Medicine and Echo Research and Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.